Manufacturers Life Insurance Company, The Merus N.V. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Merus N.V. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 51,289 shares of MRUS stock, worth $2.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,289
Previous 62,752
18.27%
Holding current value
$2.2 Million
Previous $3.71 Million
31.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MRUS
# of Institutions
200Shares Held
61.9MCall Options Held
243KPut Options Held
300K-
Rtw Investments, LP New York, NY4.17MShares$178 Million3.32% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.41MShares$146 Million3.17% of portfolio
-
Commodore Capital LP New York, NY3.35MShares$143 Million14.22% of portfolio
-
Wellington Management Group LLP Boston, MA2.89MShares$124 Million0.03% of portfolio
-
Samlyn Capital, LLC New York, NY2.61MShares$112 Million2.1% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $1.96B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...